| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/24/2013 | US8541650 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT1 polypeptides and homologs thereof |
| 09/24/2013 | US8541561 DNA aptamer specifically binding to pLDH (plasmodium lactate dehydrogenase) |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541232 Composition comprising a progenitor/precursor cell population |
| 09/24/2013 | US8541224 Serum-free growth medium for Acholeplasma laidlawii and methods for retention testing sterilizing grade filters |
| 09/24/2013 | US8541219 High fidelity reverse transcriptases and the uses thereof |
| 09/24/2013 | US8541218 High fidelity thermostable ligase and uses thereof |
| 09/24/2013 | US8541198 Method for determination and quantification of radiation or genotoxin exposure |
| 09/24/2013 | US8541197 Targets, including Yap1, for antifungal drug discovery and therapy |
| 09/24/2013 | US8541196 Method for activating a self-contained biological indicator |
| 09/24/2013 | US8541195 Method for testing a sterilization packaging unit |
| 09/24/2013 | US8541194 Detecting micro-organisms in an electrocoating process |
| 09/24/2013 | US8541193 Cationic anti-microbial peptides and methods of use thereof |
| 09/24/2013 | US8541192 Methods to identify USP1 deubiquitinating enzyme complex inhibitors |
| 09/24/2013 | US8541191 Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids |
| 09/24/2013 | US8541190 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof |
| 09/24/2013 | US8541189 Method for measuring the plasmine activity of microparticles present in a sample of blood or a blood component |
| 09/24/2013 | US8541185 Method of predicting responsiveness to autologous adoptive cell transfer therapy |
| 09/24/2013 | US8541174 Multi-array, multi-specific electrochemiluminescence testing |
| 09/24/2013 | US8541173 Endometriosis-related markers and uses thereof |
| 09/24/2013 | US8541172 Method for sequencing a polynucelotide template |
| 09/24/2013 | US8541171 Assay for detection of human parvovirus B19 nucleic acid |
| 09/24/2013 | US8541170 Methods and compositions of molecular profiling for disease diagnostics |
| 09/24/2013 | US8541169 Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations |
| 09/24/2013 | US8541167 Methods and compositions for vaccination |
| 09/24/2013 | US8541166 Peptide sequences for binding infectious prions |
| 09/24/2013 | US8541005 Cysteine-tagged streptococcal protein G variant |
| 09/24/2013 | US8540996 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| 09/24/2013 | US8540995 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof |
| 09/24/2013 | US8540994 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 09/24/2013 | US8540864 Method of measuring blood component, sensor used in the method, and measuring device |
| 09/24/2013 | US8540521 Benzoxazole-based fluorescent metal ion indicators |
| 09/24/2013 | CA2658491C Membrane-translocating peptides |
| 09/24/2013 | CA2587643C Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |
| 09/24/2013 | CA2569707C C-terminal modification of polypeptides |
| 09/24/2013 | CA2556172C Selective growth medium for listeria spp |
| 09/24/2013 | CA2520846C Aptamer selection method |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2480045C Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles |
| 09/24/2013 | CA2476410C Methods to increase or decrease bone density |
| 09/24/2013 | CA2434760C Differentiated cells suitable for human therapy |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2312478C G-protein coupled receptors and uses therefor |
| 09/23/2013 | CA2809872A1 Large deletions in human pms2 gene and use thereof |
| 09/23/2013 | CA2772338A1 The kras variant and tumor biology |
| 09/19/2013 | WO2013138767A1 Systems and methods for biological analysis |
| 09/19/2013 | WO2013138727A1 Method, kit and array for biomarker validation and clinical use |
| 09/19/2013 | WO2013138726A1 Thyroid cancer biomarker |
| 09/19/2013 | WO2013138691A1 Methods of predicting clinical outcome of chronic lymphocytic leukemia |
| 09/19/2013 | WO2013138685A1 Systems and methods for assessing of biological samples |
| 09/19/2013 | WO2013138650A1 Adenoviral tumor diagnostics |
| 09/19/2013 | WO2013138604A1 Systems and methods for reducing representations of genome sequencing data |
| 09/19/2013 | WO2013138585A1 Multiplex methods to assay mixed cell populations simultaneously |
| 09/19/2013 | WO2013138536A1 Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by a nucleic acid polymerase |
| 09/19/2013 | WO2013138527A1 Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis |
| 09/19/2013 | WO2013138510A1 Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
| 09/19/2013 | WO2013138497A1 Early detection of tuberculosis treatment response |
| 09/19/2013 | WO2013138484A1 Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin |
| 09/19/2013 | WO2013138361A1 Inhibitors of human ezh2, and methods of use thereof |
| 09/19/2013 | WO2013138300A1 Nucleic acid-based authentication codes |
| 09/19/2013 | WO2013138237A1 Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia |
| 09/19/2013 | WO2013138044A1 Methods and materials for noninvasive detection of colorectal neoplasia associated with inflammatory bowel disease |
| 09/19/2013 | WO2013137947A1 Soy gene cluster regions and methods of use |
| 09/19/2013 | WO2013137820A1 Methods and systems for the detection of methicillin resistant staphylococcus aureus |
| 09/19/2013 | WO2013137737A1 Methods of creating and screening of dna encoded combinatorial libraries of chemical antibodies |
| 09/19/2013 | WO2013137622A1 Method of culturing e. coli cells for high density |
| 09/19/2013 | WO2013137527A1 Method for isolating hepatitis a virus or spring viraemia of carp virus |
| 09/19/2013 | WO2013137475A1 Biomarker for predicting recurrence risk of endometrial cancer |
| 09/19/2013 | WO2013137328A1 Method for screening anticancer drugs, and anticancer drug that induces cell death and uses substance that increases granzyme m activity as active ingredient |
| 09/19/2013 | WO2013137255A1 Method for preparing soil microorganism and utilization of same |
| 09/19/2013 | WO2013136818A1 Method and kit for detecting macrolide antibiotic-resistant mutant bacterium |
| 09/19/2013 | WO2013136334A2 Means and methods for diagnostics and therapeutics of diseases |
| 09/19/2013 | WO2013136095A1 Peptide arrays |
| 09/19/2013 | WO2013136088A1 Method and apparatus |
| 09/19/2013 | WO2013136087A1 Method and apparatus |
| 09/19/2013 | WO2013136085A1 Method and apparatus |
| 09/19/2013 | WO2013135910A1 Method for identification of the sequence of poly(a)+rna that physically interacts with protein |
| 09/19/2013 | WO2013135889A1 Volatile biomarkers for the detection of mycotoxin-producing fungal pathogens in maize plants |
| 09/19/2013 | WO2013135830A1 Epigenetic signatures as marker for cardiomyopathies and myocardial insufficiencies |
| 09/19/2013 | WO2013135820A1 Method and kit for the detection of nucleic acids |
| 09/19/2013 | WO2013135775A1 High-resolution transcriptome of human macrophages |
| 09/19/2013 | WO2013135581A1 Immunoassay for detection of specific nucleic acid sequences such as mirnas |
| 09/19/2013 | WO2013135454A1 Epigenetic marker for the identification of cd3cd4 positive t lymphocytes |
| 09/19/2013 | WO2013134902A1 Method for carrying out speed reducing and monomer catching on nucleic acid molecule based on solid state nano-pore |
| 09/19/2013 | WO2013134860A1 Cancer biomarkers and methods of use |
| 09/19/2013 | WO2013134839A1 Differential diagnostic method and kit for infectious and parasitic diseases, using flow cytometry |
| 09/19/2013 | WO2013111953A3 Method for detecting and quantifying target proteins or target cells using aptamer chips |
| 09/19/2013 | WO2013107459A3 Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| 09/19/2013 | WO2013105833A3 Method for measuring thrombin generation |
| 09/19/2013 | WO2013089888A3 Gel-tethered molecular beacons |
| 09/19/2013 | WO2013089882A3 Recurrent gene fusions in breast cancer |
| 09/19/2013 | WO2013074125A9 Acoustic wave (aw) sensing devices using living cells |
| 09/19/2013 | WO2013023198A8 Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| 09/19/2013 | US20130247249 Gene controlling shell phenotype in palm |
| 09/19/2013 | US20130247233 G protein coupled receptors and uses thereof |
| 09/19/2013 | US20130245234 Vmp-like sequences of pathogenic borrelia |
| 09/19/2013 | US20130245135 Methods and compositions for assessing patients with preeclampsia-related conditions using microrna |
| 09/19/2013 | US20130245097 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |